References
- Ries R. Assessment and treatment of patients with coexisting mental illness and alcohol and other drug abuse. Treatment Improvement Protocol #9. Rockville, MD: Center for Substance Abuse Treatment, 1994.
- Sacks S, Ries R. Substance abuse treatment persons with co-occurring disorders. In: #42 Treatment Improvement Protocol. Rockville, MD: Center for Substance Abuse Treatment.
- Bartels S J, Drake R E, Wallach M A. Long-term course of substance use disorders among patients with severe mental disorder. Psychiatr Serv 1995; 46:248–251. [PUBMED], [INFOTRIEVE], [CSA]
- Brown R A, Monti P M, Myers M G, Martin R A, Rivinus T, Dubreuil M E, Rohsenow D J. Am J Psychiatry 1998; 155:220–225. [PUBMED], [INFOTRIEVE]
- Carroll K M, Power M E, Bryant K, Rounsaville B J. One-year follow-up status of treatment-seeking cocaine abusers: psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis 1993; 181:71–79. [PUBMED], [INFOTRIEVE]
- Case N. The dual-diagnosis patient in a psychiatric day treatment program: a treatment failure. J Subst Abuse Treat 1991; 8:69–73. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Greenberg W M, Otero J, Villanueva L. Irregular discharges from a dual diagnosis unit. Am J Drug Alcohol Abuse 1994; 20:355–371. [PUBMED], [INFOTRIEVE], [CSA]
- McLellan A T, Luborsky L, Woody G E, O'Brien C T, Druley K A. Predicting response to drug and alcohol treatment. Role of psychiatric severity. Arch Gen Psychiatry 1983; 40:620–625. [PUBMED], [INFOTRIEVE]
- Ravndal E, Vaglum P. The influence of personality disorders on treatment completion in a hierarchical therapeutic community for drug abusers: a prospective study. Eur Addict Res 1995; 1:178–186.
- Rounsaville B J, Kosten T R, Weissman M M, Kleber H D. Prognostic significance of psychopathology in treated opiate addicts: a 2.5 year follow-up study. Arch Gen Psychiatry 1986; 43:739–745. [PUBMED], [INFOTRIEVE]
- Rounsaville B J, Weissman M M, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch Gen Psychiatry 1982; 39:151–156. [PUBMED], [INFOTRIEVE]
- Saxon A J, Calsyn D A. Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic. Am J Drug Alcohol Ab 1995; 21:303–313. [CSA]
- Gillen R W, Kranzler H R, Kadden R M, Weidenman M A. Utility of a brief cognitive screening instrument in substance abuse patients: initial investigation. J Subst Abuse Treat 1991; 8:247–251. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Maude-Griffin P M, Hohenstein J M, Humfleet G L, Reilly P M, Tusel D J, Hall S M. Superior efficacy of cognitive behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol 1998; 66:832–837. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Simpson D D. Treatment for drug abuse: follow-up outcomes and length of time spent. Arch Gen Psychiatry 1981; 38:875–879. [INFOTRIEVE]
- Simpson D D, Joe G W, Brown B S. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study DATOS. Psychol Addict Behav 1997; 11:294–307. [CSA], [CROSSREF]
- Simpson D D, Joe G W. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993; 30:357–367.
- Griffith J, Knight D, Joe G, Simpson D. Implications of family and peer relations for treatment engagement and follow-up outcomes: an integrative model. Psychol Addict Behav 1998; 21:113–126.
- Joe G W, Simpson D D, Broome K M. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998; 93:1177–1190. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Simpson D D. Modeling treatment process and outcomes. Addiction 2001; 96:207–211. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Simpson D, Joe G, Greener J, Rowan-Szal G. Modeling year 1 outcomes with treatment process and post treatment social influences. Subst Use Misuse 2000; 35(12–14):1911–1930. [PUBMED], [INFOTRIEVE], [CSA]
- Brown B S, O'Grady K E, Battjes R, Farrell E. Factors associated with treatment outcomes in an aftercare population. Am J Addict. 2004; 13:446–447.
- Zachary R A. Shipley Institute of Living Scale. Revised Manual. Los Angeles, CA: Western Psychological Services, 1996.
- Zachary R A, Crumpton E, Spiegel D. Estimating WAIS-R IQ from the Shipley Institute of Living Scale. J Clin Psychol 1985; 41:532–540.
- McLellan A T, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the Addiction Severity Index: historical critique and normative data. J Subst Abuse Treat 1992; 9:199–213. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Joe G W, Simpson D D, Broome K M. Retention and patient engagement models for different treatment modalities in DATOS. Drug Alcohol Depend 1999; 57:113–125. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Beck A T, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42:861–865. [PUBMED], [INFOTRIEVE]
- Steer R, Iguchi M, Platt J. Hopelessness in IV drug users not in treatment and seeking HIV testing and counseling. Drug Alcohol Depend 1994; 34:99–103. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Katz E C, Brown B S, Schwartz R P, Weintraub E, Barksdale W, Robinson R. Role induction: a method for enhancing early retention in outpatient drug-free treatment. J Consult Clin Psychol 2004; 72:227–234. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]